個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Equicom Group inc.: The Hemosol Decision
內容大綱
Hemosol is a small biotech company that is under pressure to meet its research and development targets. The company is anticipating the completion of the second phase of testing of one of its products within the next year. Before the company can move on to the next phase of testing, Hemosol must obtain more capital. The company will need to rely on the investment community for funding, however, they have been struggling with developing relationships with investors. Hemosol's president has approached the executive vice-president of the Equicom Group Inc., an investor relations firms, for assistance in putting a strategic plan together to improve the company's performance and reputation.